40 related articles for article (PubMed ID: 5307973)
1. A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.
Heravian J; Saghafi M; Shoeibi N; Hassanzadeh S; Shakeri MT; Sharepoor M
Int Ophthalmol; 2011 Aug; 31(4):283-9. PubMed ID: 21748532
[TBL] [Abstract][Full Text] [Related]
2. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
Salu P; Uvijls A; van den Brande P; Leroy BP
Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
[TBL] [Abstract][Full Text] [Related]
3. Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.
Tzekov R
Doc Ophthalmol; 2005 Jan; 110(1):111-20. PubMed ID: 16249962
[TBL] [Abstract][Full Text] [Related]
4. Detecting chloroquine retinopathy: electro-oculogram versus colour vision.
Neubauer AS; Samari-Kermani K; Schaller U; Welge-Lübetaen U; Rudolph G; Berninger T
Br J Ophthalmol; 2003 Jul; 87(7):902-8. PubMed ID: 12812896
[TBL] [Abstract][Full Text] [Related]
5. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
Katz B
Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
[TBL] [Abstract][Full Text] [Related]
6. Ocular adverse effects of neuropsychiatric agents. Incidence and management.
Oshika T
Drug Saf; 1995 Apr; 12(4):256-63. PubMed ID: 7646824
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin retinopathy: case report and review.
Graham CM; Blach RK
Br J Ophthalmol; 1988 Jun; 72(6):434-8. PubMed ID: 3291939
[TBL] [Abstract][Full Text] [Related]
8. Some iatrogenic ocular diseases from systemically administered drugs.
Bernstein HN
Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
[No Abstract] [Full Text] [Related]
9. Chloroquine ocular toxicity.
Bernstein HN
Surv Ophthalmol; 1967 Oct; 12(5):415-47. PubMed ID: 4980087
[No Abstract] [Full Text] [Related]
10. Acquired color vision defects secondary to retinal drug toxicity.
Grützner P
Ophthalmologica; 1969; 158 Suppl():592-604. PubMed ID: 5307973
[No Abstract] [Full Text] [Related]
11. Drug-induced macular disease.
Potts AM
Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468
[No Abstract] [Full Text] [Related]
12. Detection of color vision defects in chloroquine retinopathy.
Vu BL; Easterbrook M; Hovis JK
Ophthalmology; 1999 Sep; 106(9):1799-803; discussion 1804. PubMed ID: 10485553
[TBL] [Abstract][Full Text] [Related]
13. Ocular damage in chloroquine therapy.
Nylander U
Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
[No Abstract] [Full Text] [Related]
14. [On ocular damage caused by chloroquine].
Rinaldi G; Coslovich E; Tuvo F
Minerva Med; 1971 Feb; 62(16):766-9. PubMed ID: 5313741
[No Abstract] [Full Text] [Related]
15. [Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
Jaeger W
Klin Monbl Augenheilkd; 1977 Mar; 170(3):453-60. PubMed ID: 17031
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
